Innovative Cellular Therapeutics Holdings Ltd

LYEL

Innovative Cellular Therapeutics Holdings Ltd serves as 10 percent owner at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$274.30

Net Position

Net Seller

$274.30

Companies Traded

LYEL

Active Period

Jul 2026

2 total trades

Most Recent

Sell LYEL

Jul 20, 2026 · $137.00

Innovative Cellular Therapeutics Holdings Ltd's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

0 · $0.00

Sells

2 · $274.30

Total Shares Bought

Total Shares Sold

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 20, 2026	Sell	10	$13.70	$137.00	2,857,480
Jul 17, 2026	Sell	10	$13.73	$137.30	2,857,490

Related Insiders

Gary K. Lee

officer: Chief Scientific Officer

LYELSell · Jun 15, 2026

Lynn Seely

President and CEO

LYELSell · Jun 15, 2026

Veronica Sanchez Bulis

VP, Corporate Controller

LYELSell · Jun 15, 2026

Stephen J. Hill

officer: Chief Operating Officer

LYELSell · Jun 15, 2026

David Shook

officer: Chief Medical Officer

LYELSell · Jun 11, 2026

ARCH Venture Partners IX, LLC

10 percent owner

LYELBuy · Mar 9, 2026

ARCH Venture Fund XIII, L.P.

10 percent owner

LYELBuy · Mar 9, 2026

Charles W. Newton

Chief Financial Officer

LYELSell · Aug 20, 2025

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity